The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Atropine-Global Market Insights and Sales Trends 2025
Synopsis
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
The global Atropine market size is expected to reach US$ 443.7 million by 2029, growing at a CAGR of -1.7% from 2023 to 2029. The market is mainly driven by the significant applications of Atropine in various end use industries. The expanding demands from the Gastrointestinal, Ophthalmology and Other, are propelling Atropine market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drop segment is estimated at % CAGR for the next seven-year period.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atropine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atropine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atropine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atropine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atropine covered in this report include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc.
The global Atropine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Global Atropine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atropine market, Segment by Type:
Injection
Drop
Gel
Global Atropine market, by Application
Gastrointestinal
Ophthalmology
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atropine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
The global Atropine market size is expected to reach US$ 443.7 million by 2029, growing at a CAGR of -1.7% from 2023 to 2029. The market is mainly driven by the significant applications of Atropine in various end use industries. The expanding demands from the Gastrointestinal, Ophthalmology and Other, are propelling Atropine market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drop segment is estimated at % CAGR for the next seven-year period.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atropine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atropine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atropine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atropine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atropine covered in this report include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc.
The global Atropine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Global Atropine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atropine market, Segment by Type:
Injection
Drop
Gel
Global Atropine market, by Application
Gastrointestinal
Ophthalmology
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atropine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Atropine Market Overview
1.1 Atropine Product Overview
1.2 Atropine Market Segment by Type
1.2.1 Injection
1.2.2 Drop
1.2.3 Gel
1.3 Global Atropine Market Size by Type
1.3.1 Global Atropine Market Size Overview by Type (2018-2029)
1.3.2 Global Atropine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Atropine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Atropine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Atropine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Atropine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Atropine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Atropine Sales Breakdown by Type (2018-2023)
2 Global Atropine Market Competition by Company
2.1 Global Top Players by Atropine Sales (2018-2023)
2.2 Global Top Players by Atropine Revenue (2018-2023)
2.3 Global Top Players by Atropine Price (2018-2023)
2.4 Global Top Manufacturers Atropine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Atropine Market Competitive Situation and Trends
2.5.1 Atropine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Atropine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atropine as of 2022)
2.7 Date of Key Manufacturers Enter into Atropine Market
2.8 Key Manufacturers Atropine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Atropine Status and Outlook by Region
3.1 Global Atropine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Atropine Historic Market Size by Region
3.2.1 Global Atropine Sales in Volume by Region (2018-2023)
3.2.2 Global Atropine Sales in Value by Region (2018-2023)
3.2.3 Global Atropine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Atropine Forecasted Market Size by Region
3.3.1 Global Atropine Sales in Volume by Region (2024-2029)
3.3.2 Global Atropine Sales in Value by Region (2024-2029)
3.3.3 Global Atropine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Atropine by Application
4.1 Atropine Market Segment by Application
4.1.1 Gastrointestinal
4.1.2 Ophthalmology
4.1.3 Other
4.2 Global Atropine Market Size by Application
4.2.1 Global Atropine Market Size Overview by Application (2018-2029)
4.2.2 Global Atropine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Atropine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Atropine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Atropine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Atropine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Atropine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Atropine Sales Breakdown by Application (2018-2023)
5 North America Atropine by Country
5.1 North America Atropine Historic Market Size by Country
5.1.1 North America Atropine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Atropine Sales in Volume by Country (2018-2023)
5.1.3 North America Atropine Sales in Value by Country (2018-2023)
5.2 North America Atropine Forecasted Market Size by Country
5.2.1 North America Atropine Sales in Volume by Country (2024-2029)
5.2.2 North America Atropine Sales in Value by Country (2024-2029)
6 Europe Atropine by Country
6.1 Europe Atropine Historic Market Size by Country
6.1.1 Europe Atropine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Atropine Sales in Volume by Country (2018-2023)
6.1.3 Europe Atropine Sales in Value by Country (2018-2023)
6.2 Europe Atropine Forecasted Market Size by Country
6.2.1 Europe Atropine Sales in Volume by Country (2024-2029)
6.2.2 Europe Atropine Sales in Value by Country (2024-2029)
7 Asia-Pacific Atropine by Region
7.1 Asia-Pacific Atropine Historic Market Size by Region
7.1.1 Asia-Pacific Atropine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Atropine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Atropine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Atropine Forecasted Market Size by Region
7.2.1 Asia-Pacific Atropine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Atropine Sales in Value by Region (2024-2029)
8 Latin America Atropine by Country
8.1 Latin America Atropine Historic Market Size by Country
8.1.1 Latin America Atropine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Atropine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Atropine Sales in Value by Country (2018-2023)
8.2 Latin America Atropine Forecasted Market Size by Country
8.2.1 Latin America Atropine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Atropine Sales in Value by Country (2024-2029)
9 Middle East and Africa Atropine by Country
9.1 Middle East and Africa Atropine Historic Market Size by Country
9.1.1 Middle East and Africa Atropine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Atropine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Atropine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Atropine Forecasted Market Size by Country
9.2.1 Middle East and Africa Atropine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Atropine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 C²PHARMA
10.1.1 C²PHARMA Company Information
10.1.2 C²PHARMA Introduction and Business Overview
10.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 C²PHARMA Atropine Products Offered
10.1.5 C²PHARMA Recent Development
10.2 RESONANCE LABORATORIES
10.2.1 RESONANCE LABORATORIES Company Information
10.2.2 RESONANCE LABORATORIES Introduction and Business Overview
10.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 RESONANCE LABORATORIES Atropine Products Offered
10.2.5 RESONANCE LABORATORIES Recent Development
10.3 ROLABO OUTSOURCING
10.3.1 ROLABO OUTSOURCING Company Information
10.3.2 ROLABO OUTSOURCING Introduction and Business Overview
10.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 ROLABO OUTSOURCING Atropine Products Offered
10.3.5 ROLABO OUTSOURCING Recent Development
10.4 Minsheng
10.4.1 Minsheng Company Information
10.4.2 Minsheng Introduction and Business Overview
10.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Minsheng Atropine Products Offered
10.4.5 Minsheng Recent Development
10.5 CR Double-Crane
10.5.1 CR Double-Crane Company Information
10.5.2 CR Double-Crane Introduction and Business Overview
10.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CR Double-Crane Atropine Products Offered
10.5.5 CR Double-Crane Recent Development
10.6 HENAN PURUI
10.6.1 HENAN PURUI Company Information
10.6.2 HENAN PURUI Introduction and Business Overview
10.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 HENAN PURUI Atropine Products Offered
10.6.5 HENAN PURUI Recent Development
10.7 Albany Molecular Research
10.7.1 Albany Molecular Research Company Information
10.7.2 Albany Molecular Research Introduction and Business Overview
10.7.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Albany Molecular Research Atropine Products Offered
10.7.5 Albany Molecular Research Recent Development
10.8 Alchem International
10.8.1 Alchem International Company Information
10.8.2 Alchem International Introduction and Business Overview
10.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Alchem International Atropine Products Offered
10.8.5 Alchem International Recent Development
10.9 SAURAV CHEMICALS
10.9.1 SAURAV CHEMICALS Company Information
10.9.2 SAURAV CHEMICALS Introduction and Business Overview
10.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 SAURAV CHEMICALS Atropine Products Offered
10.9.5 SAURAV CHEMICALS Recent Development
10.10 Katsura Chemical
10.10.1 Katsura Chemical Company Information
10.10.2 Katsura Chemical Introduction and Business Overview
10.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Katsura Chemical Atropine Products Offered
10.10.5 Katsura Chemical Recent Development
10.11 Hangzhou Vega
10.11.1 Hangzhou Vega Company Information
10.11.2 Hangzhou Vega Introduction and Business Overview
10.11.3 Hangzhou Vega Atropine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hangzhou Vega Atropine Products Offered
10.11.5 Hangzhou Vega Recent Development
10.12 Wuhan senwayer century
10.12.1 Wuhan senwayer century Company Information
10.12.2 Wuhan senwayer century Introduction and Business Overview
10.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Wuhan senwayer century Atropine Products Offered
10.12.5 Wuhan senwayer century Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Atropine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Atropine Industrial Chain Analysis
11.4 Atropine Market Dynamics
11.4.1 Atropine Industry Trends
11.4.2 Atropine Market Drivers
11.4.3 Atropine Market Challenges
11.4.4 Atropine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Atropine Distributors
12.3 Atropine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
